Table 7.
Cox proportional hazard analysis with bivariate and multivariate model for socio demographic, clinical and laboratory, HIV patients on HAART in St.Luke and Tulu Bolo Hospital, Ethiopia from April 2006-July 2013. (n=828)
| Variable | Immunological failure (%) | Immunological success (%) | Crude HR (95% CI) | Adjusted HR# (95% CI) |
|---|---|---|---|---|
| Disclosure status | ||||
| Yes | 38(6.8) | 517(93.2) | 2.056(1.120-3.774) | 0.429(0.206-0.893)@ |
| No | 18(6.6) | 255(93.4) | 1 | 1 |
| WHO stage | ||||
| Stage 1 | 17(6.1) | 264(93.9) | 1 | |
| Stage 2 | 25(7.9) | 291(92.1) | 1.916 (0.637-5.761) | |
| Stage3 | 10(5.5) | 173(94.5) | 1.182(0.408-3.426) | |
| Stage4 | 4(8.3) | 44(91.7) | 1.124 (0. 342-3.688) | |
| Base line CD4 count (N=820) | 0.517(0.253-1.057) | |||
| <=200 | 38(6.1) | 581(93.9) | 0.469 (0.252-0.872) | |
| > 200 | 16(8) | 185(92) | 1 | |
| Functional status | ||||
| Working | 43(6.4) | 627(93.6) | 1 | 1 |
| Ambulatory | 11(8.3) | 102(91.7) | 0. 557 (0.274-1.130) | 0.337(0.137-0.828)@ |
| Bedridden | 2(8) | 23(92) | 1.044 (0 .250-4.354) | 0.599(0.111-3.216) |
| Weight | ||||
| <50 | 34(7.4) | 427(92.6) | 0.718 (0.412-1.253) | |
| >=50 | 22(6) | 345(94) | 1 |
#
HR- Hazard Ratio
@
Statistically significant